About this trial
Milk and dairy products contain significant amounts of nutrients that contribute to optimal health - nutrients like calcium, vitamin D, and high-quality protein. Fermented milk products or fermented dairy products are dairy foods that have been fermented with certain bacteria. Yogurt is a fermented dairy product containing millions of beneficial bacteria. In this study, the invesgitagtors will look at the effect of milk (a non-fermented dairy product) and yogurt (a fermented dairy product) supplementation on bone health and the amount of fat and muscle mass in Canadian young adults over a 24-month period. While dairy products contain significant amounts of nutrients, the scientific community does not know the impact of long-term supplementation of fermented (i.e., yogurt) or non-fermented (i.e., milk) dairy food on bone health and the amount of fat and muscle mass in young adults. To fill this knowledge gap, the investigators will recruit participants with low calcium intake and assign them to three different groups: 1) milk (intervention) group; 2) yogurt (intervention) group; and 3) control group. The investigators will ask the participants in the milk group to drink 1.5 servings (375 mL) of milk per day for 24 months. Participants in the yogurt group will consume 2 servings (350 g) of yogurt per day for 24 months. Those in the control group will continue their usual diets. Using a randomized controlled trial design, the investigators will measure bone health parameters, hormonal indices related to bone metabolism, body composition (e.g., muscle mass, fat mass), and the number and composition of bacteria living in the gastrointestinal (GI) tract. The hypothesis is that supplementation with yogurt will have more positive effects on bone health indices, particularly femoral neck BMD as the primary outcome, than milk in Canadian adults aged 19-30 years. The secondary hypothesis is that supplementation with yogurt, as a fermented milk product, will have a more beneficial effect than milk on body composition measures. The data will provide valuable information for developing targeted health initiatives and marketing strategies regarding the benefits of fermented and non-fermented dairy product consumption.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
19-30 years old
Dietary calcium intake below 1000mg/ day
living in the Saskatoon area (Saskatchewan, Canada)
Disqualifiers
Calcium intake from both food and supplement above the estimated average requirement (EAR) for adults aged 19-30 years (>800 mg/day)
Total dairy intake of more than 1 serving per day
Body mass index greater than to 30 kg/m2
Medical history of metabolic bone, liver, endocrine, connective tissue, and respiratory diseases, thyroid disorders, or cancer
Trial design
Parallel
Treatments tested in this trial
Habitual Diet + Milk
Other intervention1.5 servings of milk \[providing approx. 500 mg Ca/day\] per day (either 1% fat milk, or 2% fat milk)
Habitual Diet + Yogurt
Other intervention2 servings of yogurt \[providing approx. 500 mg Ca/day\] per day (either 1% fat plain yogurt, 2% fat plain yogurt, 1% fat flavoured yogurt, 2% fat flavoured yogurt)
Treatment groups
Trial outcomes
Primary outcomes
Femoral neck bone mineral density
Measurement will be done via Dual Energy X-ray Absorptiometry.
Secondary outcomes
Bone mineral density (total hip, lumbar spine, whole body)
Measurement will be done via Dual Energy X-ray Absorptiometry.
Bone mineral content (total hip, femoral neck, lumbar spine, whole body)
Measurement will be done via Dual Energy X-ray Absorptiometry.
Other outcomes
Bone structure
Measurement via HR-pQCT scan at distal radius and tibia
Bone geometry
Measurement via HR-pQCT scan at distal radius and tibia
Serum bone alkaline phosphatase (biochemical indices of bone turnover)
Fasting blood sample will be collected from each participant between 8 a.m. and 10 a.m. after an overnight fast of 12 hours with no heavy exercise/workouts 48 hours prior to blood collection into 2 x 4ml serum separating tubes (SST) for the analysis of all serum measures.
Serum osteocalcin (biochemical indices of bone turnover)
Fasting blood sample will be collected from each participant between 8 a.m. and 10 a.m. after an overnight fast of 12 hours with no heavy exercise/workouts 48 hours prior to blood collection into 2 x 4ml serum separating tubes (SST) for the analysis of all serum measures.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Saskatchewan
Lead sponsor
Dairy Farmers of Canada
Collaborator
Agriculture and Agri-Food Canada
Collaborator